Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.45    -0.20 (-2.31%)
Bid:
8.30
Ask:
8.60
Spread: 0.30 (3.614%)
Market Cap: £18.43m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Annual Information Update

7 Feb 2011 12:18

RNS Number : 7974A
Phytopharm PLC
07 February 2011
 

Phytopharm plc

 

Annual Information Update

 

Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 31 January 2011, the following information has been published or made available to the public between 14 December 2009 and 7 February 2011 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.

1. Announcements made via the Regulatory Information Service ("RIS")

All the announcements listed below were published through a regulatory information service on the dates indicated. Copies can be obtained from the London Stock Exchange website, http://www.londonstockexchange.com or from the Company's website www.phytopharm.com

Date of publication

Title

1 February 2011

Total voting rights

1 February 2011

Annual Report 2010 and notice of 2011 AGM

19 January 2011

Director/PDMR shareholding

19 January 2011

Director/PDMR shareholding

14 January 2011

Holdings in Company

10 January 2011

Holdings in Company

7 January 2011

Block Listing Application

4 January 2011

Total voting rights

21 December 2010

Director/PDMR shareholding

21 December 2010

Director/PDMR shareholding

14 December 2010

Block Listing application

30 November 2010

Final results

17 November 2010

Research update

3 November 2010

Block listing interim review

1 November 2010

Preliminary results - change of date

1 November 2010

Notice of preliminary results

29 September 2010

Presentation at scientific conference

18 August 2010

Interim management statement

22 July 2010

Director/PDMR shareholding

22 July 2010

Director/PDMR shareholding

5 July 2010

Change of registered office

21 June 2010

Appointment of Chief Executive Officer

14 June 2010

Regulatory approval to begin Cogane™ Phase II trial

24 May 2010

Half yearly report

19 May 2010

Notice of results

4 May 2010

Block listing interim review

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

31 March 2010

Results of Annual General Meeting

2 March 2010

Notice of Annual General Meeting

11 February 2010

Interim Management Statement

15 January 2010

Appointment of R & D Director

5 January 2010

Holding in company

4 January 2010

Total voting rights

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

29 December 2009

GM results

22 December 2009

Open Offer results

15 December 2009

Correction to Form of Proxy

15 December 2009

Annual Information update

14 December 2009

Presents data at XVIII WFN Congress

2. Documents published or sent to Shareholders, filed with the UK Listing Authority or submitted to the FSA including those filed with the National Storage Mechanism:

Date of publication

Title

1 February 2011

Notice of 2011 Annual General Meeting

1 February 2011

Annual Report 2010

2 June 2010

Interim Report 2010

31 March 2010

AGM resolutions

2 March2010

Notice of Annual General Meeting

30 December 2009

General Meeting resolutions

The 2010 Interim and 2010 Annual reports are available on the Company's website www.phytopharm.com

3. Documents filed at Companies House

The following documents were files at Companies House. Copies of these documents can be obtained from the Companies House website at www.companieshouse.gov.uk, or Companies House, Crown Way, Cardiff CF14 3UZ

Date of Publication

Title

25 January 2011

Form SH01 Return of allotment of shares on 14 January 2011

5 January 2011

Form SH01 Return of allotment of shares on 16 December 2010

16 December 2010

Form AR01 Annual return

6 July 2010

Form AP01 Appointment of director

6 July 2010

Form AD01 change of registered office address

31 March 2010

Articles of Association approved by shareholders on 30 march 2010

31 March 2010

Annual General Meeting resolutions

25 January 2010

Form AP01 Appointment of director

4 January 2010

Form SH01 Return of allotment of shares on 29 December 2009

Copies of all documents referred to above are also available for inspection at the Company's registered office (Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambs PE29 6UA, United Kingdom) during normal business hours or by written request from the Company Secretary.

This annual information is required by, and is being made pursuant to, Article 10 of the Prospectus Directive as implemented by the UK Prospectus Rule 5.2 and not for any other purpose and neither the Company, nor any other person, takes any responsibility for, or makes any representation, express of implied, as to the accuracy or completeness of, the information which it contains. The information is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Neither this annual information update, not referred to in it, constitutes, by virtue of this communication, an offer of securities addressed to any person and it should not be relied on by any person.

For further information, please contact:

Zoe McGowan, Company Secretary

Phytopharm plc Tel No: +44 (0)1480 437697

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUEAAAXEFAFEFF
Date   Source Headline
22nd Aug 20197:00 amRNSDirectorate Change
20th Aug 20195:38 pmRNSDirector/PDMR Shareholding
19th Aug 20194:40 pmRNSSecond Price Monitoring Extn
19th Aug 20194:35 pmRNSPrice Monitoring Extension
19th Aug 20197:00 amRNSTrading Update
9th Aug 20197:00 amRNSIXICO provides update on new & current contracts
23rd Jul 201911:05 amRNSSecond Price Monitoring Extn
23rd Jul 201911:00 amRNSPrice Monitoring Extension
11th Jul 20197:00 amRNSDirector and PDMR share purchase
10th Jun 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
22nd May 20197:00 amRNSHalf Yearly Report to 31 March 2019
10th May 20197:00 amRNSNotice of Results
25th Apr 20197:00 amRNSUpdate for first half of year ending 31 March 2019
24th Apr 20197:00 amRNSAnnounces two new biopharmaceutical contracts
12th Apr 20197:00 amRNSChange of Adviser
19th Mar 20194:20 pmRNSHolding(s) in Company
18th Mar 201912:24 pmRNSDirector/PDMR Shareholding
13th Mar 20197:00 amRNSDirector/PDMR Shareholding
5th Mar 20197:00 amRNSLate phase clinical study in Huntington's disease
1st Mar 20197:00 amRNSIXICO chosen for new Medical Imaging & AI Centre
7th Feb 20197:00 amRNSAppointment of Chief Financial Officer
11th Dec 20187:00 amRNSDirectorate Change
4th Dec 20187:00 amRNSFinal Results
4th Dec 20187:00 amRNSScope expanded with top 10 biopharma company
15th Oct 20187:00 amRNSPre-Close Trading Update
21st Sep 20184:46 pmRNSResult of General Meeting - Amended
21st Sep 201811:00 amRNSResult of General Meeting
11th Sep 20187:00 amRNSContract with top 10 global pharmaceutical company
3rd Sep 20187:00 amRNSProposed Capital Reorganisation
30th Aug 20187:00 amRNSContract expansion with biopharmaceutical company
21st Aug 20187:00 amRNSTrading Statement
13th Aug 20187:00 amRNSAgreement
13th Jun 20189:00 amRNSImplementation of Long Term Incentive Plan
12th Jun 20187:00 amRNSNotification of the cessation of a clinical trial
7th Jun 20189:47 amRNSIssue of Equity
31st May 20183:32 pmRNSHolding(s) in Company
31st May 20183:30 pmRNSHolding(s) in Company
30th May 201811:48 amRNSHolding(s) in Company
30th May 201811:45 amRNSHolding(s) in Company
30th May 20189:32 amRNSDirector/PDMR Shareholding
29th May 201812:08 pmRNSResult of General Meeting
23rd May 20183:29 pmRNSDirector/PDMR Shareholding
23rd May 20187:00 amRNSHalf-year Report
14th May 20187:00 amRNSNew contract with top 10 pharmaceutical company
10th May 20187:00 amRNSExpansion of two biopharmaceutical contracts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.